Name: Teva Pharmaceutical Industries Limited (TEVA) Balance Sheet
Creator: FinSpry

Teva Pharmaceutical Industries Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Teva Pharmaceutical Industries Limited (TEVA) - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	3.56	3.30	3.23	2.80	2.17	2.18	1.98	1.78
Cash & Short-Term Investments	3.56	3.30	3.23	2.80	2.17	2.18	1.98	1.78
Accounts Receivable	3.71	3.06	3.41	3.70	4.53	4.58	5.68	5.82
Inventory	3.18	3.01	4.02	3.83	3.82	4.40	4.42	4.73
Other Current Assets	1.12	1.01	0.51	0.56	0.97	0.90	0.52	0.47
Total Current Assets	13.95	12.55	12.49	12.05	12.57	13.01	13.46	13.79
Non-Current Assets
Property, Plant & Equipment (Net)	4.43	4.95	6.15	6.16	6.48	6.86	6.95	6.87
Long-Term Investments	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Goodwill	16.00	15.15	17.18	17.63	20.04	20.62	0.00	0.00
Intangible Assets	3.78	4.42	5.39	6.27	7.47	8.92	0.00	0.00
Other Non-Current Assets	0.41	0.46	0.47	0.44	0.52	0.54	0.59	0.73
Total Non-Current Assets	26.80	26.77	30.99	31.96	35.09	37.64	44.01	46.89
Total Assets	40.75	39.33	43.48	44.01	47.67	50.64	57.47	60.68
Current Liabilities
Accounts Payable	2.53	2.20	2.60	1.89	1.69	1.76	1.72	3.72
Short-Term Debt	1.82	1.78	1.67	2.11	1.43	3.19	0.00	0.00
Current Portion of Long-Term Debt	0.00	1.78	1.67	2.11	1.43	3.19	0.00	0.00
Accrued Liabilities	3.43	5.65	2.77	4.96	2.21	5.35	0.00	0.00
Other Current Liabilities	5.68	3.07	1.06	1.57	0.90	1.62	1.58	0.80
Total Current Liabilities	13.46	12.80	12.25	11.47	11.03	6.56	5.65	14.32
Non-Current Liabilities
Long-Term Debt	14.99	16.00	18.16	19.45	21.62	23.21	25.00	26.70
Deferred Tax Liabilities	0.30	0.48	0.61	0.55	0.78	0.96	0.00	0.00
Other Non-Current Liabilities	3.81	3.95	4.02	3.95	2.58	2.24	2.64	0.00
Total Non-Current Liabilities	19.38	20.81	23.11	23.94	25.40	28.19	30.60	30.57
Total Liabilities	32.83	33.61	35.35	35.41	36.42	34.76	36.25	44.89
Stockholders' Equity
Common Stock	7.91	0.06	0.06	0.06	0.06	0.06	0.00	0.00
Retained Earnings	-13.76	-15.17	-13.53	-15.81	-10.53	-13.35	-9.27	0.00
Accumulated Other Comprehensive Income	-2.39	-3.15	-2.70	3.75	-2.68	4.82	6.16	0.00
Treasury Stock	4.13	4.13	4.13	-4.13	4.13	-4.13	-4.13	0.00
Additional Paid-in Capital	28.13	27.76	27.81	27.69	27.56	27.44	27.31	0.00
Minority Interest	0.00	0.35	0.62	0.79	0.97	1.04	1.09	1.09
Shares Outstanding	1.15	1.13	1.12	1.11	1.10	0.00	0.00	0.00
Total Stockholders' Equity	7.91	5.72	7.51	8.60	10.28	15.89	21.22	15.79
Total Liabilities & Equity	40.75	39.33	43.48	44.01	47.67	50.64	57.47	60.68